<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: Medical Xpress news tagged with: vein graft</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Prehospital antiplatelets improve graft intervention outcomes</title>
   	 <description>(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous vein graft (SVG) intervention, according to research published in the Jan. 15 issue of The American Journal of Cardiology.</description>
	  <link>http://medicalxpress.com/news/2013-01-prehospital-antiplatelets-graft-intervention-outcomes.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 28 Jan 2013 13:20:05 EST</pubDate>
	 <guid isPermaLink="false">news278599665</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/prehospitala.jpg" width="90" height="90" />
</item>
<item>
     <title>Smoking affects heart surgery outcome even a year after quitting</title>
   	 <description>Smoking cessation even a year prior to coronary artery bypass grafting (CABG) surgery does not fully normalize the changes smoking has made to the saphenous (leg) veins used for the surgery and may lead to later graft failure, according to a study published in the January 2013 issue of The Annals of Thoracic Surgery.</description>
	  <link>http://medicalxpress.com/news/2013-01-affects-heart-surgery-outcome-year.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 02 Jan 2013 11:05:57 EST</pubDate>
	 <guid isPermaLink="false">news276347134</guid>
	 
</item>
<item>
     <title>Improving the safety of angioplasty in patients with coronary bypass graft disease</title>
   	 <description>Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.</description>
	  <link>http://medicalxpress.com/news/2012-10-safety-angioplasty-patients-coronary-bypass.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 22 Oct 2012 09:09:31 EST</pubDate>
	 <guid isPermaLink="false">news270115762</guid>
	 
</item>
<item>
     <title>University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care</title>
   	 <description>The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator.</description>
	  <link>http://medicalxpress.com/news/2011-06-university-louisville-surgeons-prosthetic-bypass.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 17 Jun 2011 14:38:58 EST</pubDate>
	 <guid isPermaLink="false">news227540311</guid>
	 
</item>


</channel>
</rss>
